Immunotherapy & thoracic cancers

Thoracic malignancies present a significant global health burden with the incidence and mortality of both lung cancer and malignant pleural mesothelioma (MPM) increasing by year. Lung cancer, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), is the leading cause of cancer-related deaths, worldwide.